division of NanoInk®, launched a new Web site today, which is dedicated
to providing useful information and resources to fight illegal diversion and
counterfeiting of pharmaceuticals. The new Web site, www.nanoguardian.net,
also provides detailed information on NanoGuardian's state-of-the-art, on-dose
brand protection solution, NanoEncryption™ technology and NanoGuardian's
proactive market-monitoring program, Closed-Loop Protection™.
"The new NanoGuardian Web site is a resource for those in government,
law enforcement and any industry that is affected by illegal counterfeiting
and diversion of its products," said Dean Hart, executive vice president
of NanoGuardian. "We also encourage visitors to learn about our novel NanoEncryption
technology, which is the only on-dose, multi-layered, brand protection solution
that enables pharmaceutical manufacturers to trace and authenticate every single
dose from plant to patient. Complementing our NanoEncryption technology is our
Closed-Loop Protection market-monitoring program, which serves as an early warning
system to manufacturers in the detection of counterfeit and diverted product."
The Web site also provides continuous updates on new reports of counterfeited
and illegally diverted products in the marketplace as well as past press releases
and news articles.